Neuroradiologist Keith Cauley has identified an MRI method that can better detect mini strokes, and could help prevent major strokes if used routinely whenever stroke is suspected.
Scientists at the UMass Medical School have identified a novel gene that calibrates circadian rhythms in the experimental model organism Drosophila, and that may have potential implications for neurodegenerative disorders in humans including spinocerebellar ataxia, amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.
A new feasibility study conducted by Elena Salmoirago-Blotcher, MD, PhD, indicates that delivering mindfulness training by phone may be an effective way to treat anxiety in patients who recently had cardiac defibrillators implanted.
An internationally recognized expert in viruses, Robert W. Finberg, MD, the Richard M. Haidack Professor of Medicine and chair and professor of medicine, spoke to the Boston Globe about a new study that details an innovative method of using the genetic code of a flu virus to design its vaccine.
UMMS cancer experts say findings from two new studies show that cancer may be better defined by its genetics than the organ in which it originates. The findings will be brought to bear on research and treatment at the Cancer Center of Excellence.
Victor Ambros is interviewed for the Journal of Cell Biology’s “People & Ideas” column.
The Boston Globe is reporting on the announcement of nine new Howard Hughes Medical Institute investigators from Massachusetts, including Marc R. Freeman, PhD, associate professor of neurobiology.
Marc R. Freeman, PhD, associate professor of neurobiology and a leader in the study of glial cells, has been named a Howard Hughes Medical Institute Investigator. He joins five other HHMI Investigators at UMass Medical School.